Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients

被引：0

作者：

Eiji Shinto

Eiji Oki

Mototsugu Shimokawa

Shigeki Yamaguchi

Megumi Ishiguro

Seiji Hasegawa

Yasumasa Takii

Hideyuki Ishida

Tetsuya Kusumoto

Masaru Morita

Naohiro Tomita

Manabu Shiozawa

Masafumi Tanaka

Heita Ozawa

Yojiro Hashiguchi

Shinobu Ohnuma

Sachiyo Tada

Tomoko Matsushima

Keisuke Yamagishi

Kazuo Hase

机构：

[1] National Defense Medical College,Department of Surgery

[2] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences

[3] Yamaguchi University Graduate School of Medicine,Department of Biostatistics

[4] Tokyo Women’s Medical University,Department of Surgery, Division of Colorectal Surgery

[5] Tokyo Medical and Dental University,Medical Innovation Promotion Center

[6] Saiseikai Yokohamashi Nanbu Hospital,Department of Surgery

[7] Niigata Cancer Center Hospital,Department of Gastroenterological Surgery

[8] Saitama Medical Center,Department of Digestive Tract and General Surgery

[9] Saitama Medical University,Department of Gastroenterological Surgery, Clinical Research Center, Cancer Research Division

[10] National Hospital Organization Kyushu Medical Center,Department of Gastroenterological Surgery

[11] National Hospital Organization Kyushu Cancer Center,Cancer Treatment Center

[12] Toyonaka Municipal Hospital,Department of Gastrointestinal Surgery

[13] Kanagawa Cancer Center,Coloproctology Center

[14] Takano Hospital,Department of Colorectal Surgery

[15] Tochigi Cancer Center,Department of Surgery

[16] Teikyo University School of Medicine,Department of Surgery

[17] Tohoku University Hospital,LS Business

[18] Sysmex Corporation,undefined

来源：

Annals of Surgical Oncology | 2023年 / 30卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：5239 / 5247

页数：8

共 50 条

[1] Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients
Shinto, Eiji
Oki, Eiji
Shimokawa, Mototsugu
Yamaguchi, Shigeki
Ishiguro, Megumi
Hasegawa, Seiji
Takii, Yasumasa
Ishida, Hideyuki
Kusumoto, Tetsuya
Morita, Masaru
Tomita, Naohiro
Shiozawa, Manabu
Tanaka, Masafumi
Ozawa, Heita
Hashiguchi, Yojiro
Ohnuma, Shinobu
Tada, Sachiyo
Matsushima, Tomoko
Yamagishi, Keisuke
Hase, Kazuo
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (08) : 5239 - 5247
[2] ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients
Shinto, Eiji
Oki, Eiji
Shimokawa, Mototsugu
Yamaguchi, Shigeki
Ishiguro, Megumi
Hasegawa, Seiji
Takii, Yasumasa
Ishida, Hideyuki
Kusumoto, Tetsuya
Morita, Masaru
Tomita, Naohiro
Shiozawa, Manabu
Tanaka, Masafumi
Ozawa, Heita
Hashiguchi, Yojiro
Ohnuma, Shinobu
Tada, Sachiyo
Matsushima, Tomoko
Yamagishi, Keisuke
Hase, Kazuo
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (8) : 5250 - 5251
[3] ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients
Eiji Shinto
Eiji Oki
Mototsugu Shimokawa
Shigeki Yamaguchi
Megumi Ishiguro
Seiji Hasegawa
Yasumasa Takii
Hideyuki Ishida
Tetsuya Kusumoto
Masaru Morita
Naohiro Tomita
Manabu Shiozawa
Masafumi Tanaka
Heita Ozawa
Yojiro Hashiguchi
Shinobu Ohnuma
Sachiyo Tada
Tomoko Matsushima
Keisuke Yamagishi
Kazuo Hase
Annals of Surgical Oncology, 2023, 30 : 5250 - 5251
[4] Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer
Touchefeu, Yann
Provost-Dewitte, Marie
Lecomte, Thierry
Morel, Alain
Valo, Isabelle
Mosnier, Jean-Francois
Bossard, Celine
Eugene, Juliette
Duchalais, Emilie
Chetritt, Jerome
Guyetant, Serge
Bezieau, Stephane
Senellart, Helene
Caulet, Morgane
Cauchin, Estelle
Matysiak-Budnik, Tamara
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (12) : 1394 - 1399
[5] Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
Vinal, David
Martinez-Recio, Sergio
Martinez-Perez, Daniel
Ruiz-Gutierrez, Iciar
Jimenez-Bou, Diego
Pena-Lopez, Jesus
Alameda-Guijarro, Maria
Martin-Montalvo, Gema
Rueda-Lara, Antonio
Gutierrez-Sainz, Laura
Elena Palacios, Maria
Belen Custodio, Ana
Ghanem, Ismael
Feliu, Jaime
Rodriguez-Salas, Nuria
CANCERS, 2022, 14 (23)
[6] Clinical score to predict recurrence in patients with stage II and III colon cancer
Vinal, D.
Martinez-Recio, S.
Martinez Perez, D.
Jimenez-Bou, D.
Ruiz, I.
Pena, J.
Martin-Montalvo, G.
Alameda, M.
Rueda-Lara, A.
Gutierrez-Sainz, L.
Palacios, M.
Custodio, A.
Ghanem, I.
Feliu, J.
Rodriguez-Salas, N.
ANNALS OF ONCOLOGY, 2022, 33 : S279 - S279
[7] A CIRCRNA SIGNATURE PREDICTS POSTOPERATIVE RECURRENCE IN STAGE II/III COLON CANCER
Ju, Huai-Qiang
Zhao, Qi
Wang, Feng
Lan, Ping
Wang, Zixian
Xu, Rui-Hua
GUT, 2019, 68 : A30 - A30
[8] A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
Ju, Huai-Qiang
Zhao, Qi
Wang, Feng
Lan, Ping
Wang, Zixian
Zuo, Zhi-Xiang
Wu, Qi-Nian
Fan, Xin-Juan
Mo, Hai-Yu
Chen, Li
Li, Ting
Ren, Chao
Wan, Xiang-Bo
Chen, Gong
Li, Yu-Hong
Jia, Wei-Hua
Xu, Rui-Hua
EMBO MOLECULAR MEDICINE, 2019, 11 (10)
[9] Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
Mayanagi, Shuhei
Kashiwabara, Kosuke
Honda, Michitaka
Oba, Koji
Aoyama, Toru
Kanda, Mitsuro
Maeda, Hiromichi
Hamada, Chikuma
Sadahiro, Sotaro
Sakamoto, Junichi
Saji, Shigetoyo
Yoshikawa, Takaki
DISEASES OF THE COLON & RECTUM, 2018, 61 (07) : 803 - 808
[10] Oncotype DX® colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence
You, Y. Nancy
Rustin, Rudolph B.
Sullivan, James D.
SURGICAL ONCOLOGY-OXFORD, 2015, 24 (02): : 61 - 66

← 1 2 3 4 5 →